Botulinum toxin A for treating blepharospasm or hemifacial spasm

Published on 02 Sep 2019
Last Updated on 02 Sep 2019

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has recommended:

• Clostridium botulinum toxin type A neurotoxin complex (Botox) 50 U and 100 U injection vials for treating adults with blepharospasm or hemifacial spasm.

Botulinum toxin A must be administered by a neurologist trained in movement disorder or a specialist physician who has undergone training to administer botulinum toxin type A to patients with movement disorders.

Subsidy status

Clostridium botulinum toxin type A neurotoxin complex (Botox) 50 U and 100 U injection vials are recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indications.

MAF does not apply to Botox 200 U injection vial, Dysport 300 U and 500 U injection vials and Xeomin 50 U and 100 U injection vials.

Botulinum toxin A for blepharospasm or hemifacial spasm (2 Sep 2019) [PDF, 150 KB]

PES Botulinum toxin A for treating blepharospasm or hemifacial spasm (Published 2 Sep 2019) [PDF, 186 KB]